Department of Medicine, Stavanger University Hospital, Stavanger.
Department of Global Public Health and Primary Care, University of Bergen, Bergen.
Diabet Med. 2019 Nov;36(11):1431-1443. doi: 10.1111/dme.13842. Epub 2018 Nov 27.
To assess population, general practitioner (GP) and practice characteristics associated with the performance of microvascular screening procedures and to propose strategies to improve Type 2 diabetes care.
A cross-sectional survey in Norway (281 GPs from 77 practices) identified 8246 people with a Type 2 diabetes duration of 1 year or more. We used multilevel regression models with either the recording of at least two of three recommended screening procedures (albuminuria, monofilament, eye examination) or each procedure separately as dependent variable (yes/no), and characteristics related to the person with diabetes, GP or practice as independent variables.
The performance of recommended screening procedures was recorded in the following percentages: albuminuria 31.5%, monofilament 27.5% and eye examination 60.0%. There was substantial heterogeneity between practices, and between GPs within practices for all procedures. Compared with people aged 60-69 years, those aged < 50 years were less likely to have an albuminuria test performed [odds ratio (OR) 0.75, 95% CI 0.61 to 0.93] and eye examination (OR 0.79, 95% CI 0.66 to 0.95). People with macrovascular disease had fewer screening procedures recorded (OR 0.68, 95% CI 0.59 to 0.78). Use of an electronic diabetes form was associated with improved screening (OR 2.65, 95% CI 1.86 to 3.78). GPs with high workload recorded fewer procedures (OR 0.59, 95% CI 0.39 to 0.90).
Performance of screening procedures was suboptimal overall, and in people who should be prioritized. Performance varied substantially between GPs and practices. The use of a structured diabetes form should be mandatory.
评估与微血管筛查程序执行相关的人群、全科医生(GP)和实践特征,并提出改善 2 型糖尿病护理的策略。
在挪威进行了一项横断面调查(来自 77 个实践的 281 名 GP),共确定了 8246 名 2 型糖尿病病程 1 年以上的患者。我们使用多水平回归模型,以至少执行三种推荐筛查程序中的两种(蛋白尿、单丝纤维、眼部检查)或分别以每种程序为因变量(是/否),并以与糖尿病患者、GP 或实践相关的特征为自变量。
推荐的筛查程序执行率如下:蛋白尿 31.5%,单丝纤维 27.5%,眼部检查 60.0%。所有程序在实践之间以及实践内的 GP 之间都存在很大的异质性。与 60-69 岁的患者相比,<50 岁的患者进行蛋白尿检测的可能性较低[比值比(OR)0.75,95%置信区间(CI)0.61 至 0.93]和眼部检查(OR 0.79,95% CI 0.66 至 0.95)。患有大血管疾病的患者记录的筛查程序较少(OR 0.68,95% CI 0.59 至 0.78)。使用电子糖尿病表格与改善筛查相关(OR 2.65,95% CI 1.86 至 3.78)。工作量高的 GP 记录的程序较少(OR 0.59,95% CI 0.39 至 0.90)。
总体而言,筛查程序的执行情况并不理想,特别是在应优先考虑的人群中。GP 和实践之间的表现差异很大。应强制使用结构化的糖尿病表格。